Apathy and dementia. Nosology, assessment and management

Journal of Nervous and Mental Disease

Volumn 202, Issue 10, 2014, Pages 718-724

  Cipriani, Gabriele ^a   Lucetti, Claudio ^a   Danti, Sabrina ^a   Nuti, Angelo ^a  

^a Hospital of Viareggio   (Italy)

Author keywords

Alzheimer's disease; Apathy; Behavioral and psychological symptoms; Dementia; Dementia associated with Parkinson's disease; Frontotemporal dementia; Huntington's disease; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; APATHY; DATA BASE; DEMENTIA; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; REVIEW; CLASSIFICATION; COMPLICATION; PHYSIOLOGY;

APATHY; DEMENTIA; HUMANS;

EID: 84915749198     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0000000000000190     Document Type: Review

References (95)

1. Aarsland D, Bronnick K, Ehrt U., De Deyn PP, Tekin S, Emre M, Cummings J.L. (2007) Neuropsychiatric symptoms in patients with PD and dementia: frequency, profile and associated caregiver stress. J Neurol Neurosurg Psychiatry. 78:36-42.
2. Aarsland D, Cummings JL, Larsen J.P. (2001a) Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 16:184-191.
3. Aarsland D, Litvan I, Larsen J.P. (2001b) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 13:42-49.
4. Aharon-Peretz J., Kliot D, Tomer R. (2000) Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the Neuropsychiatric Inventory. Dement Geriatr Cogn Disord. 11:294-298.
5. Allman JM, Hakeem A, Erwin J.M., Nimchinsky E., Hof P. (2001) The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci. 935:107-117.
6. American Psychiatric Association (Ed) (2013) Diagnostic and Statistical Manual of Mental Disorders, DSM-5 ed. Washington, DC: American Psychiatric Association.
7. Anderson KE, Louis ED, Stern Y, Marder K.S. (2001) Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. Am J Psychiatry. 158: 799-801.
8. Aupperle PM, Koumaras B, Chen M., Rabinowicz A, Mirski D. (2004) Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Currm Med Res Opin. 20:1605-1612.
9. Baudic S, Maison P, Dolbeau G., Boissé MF, Bartolomeo P, Dalla Barba G, Traykov L, Bachoud-Lévi AC (2006) Cognitive impairment related to apathy in early Huntington's disease. Dement Geriatr Cogn Disord. 21:316-321.
10. Benoit M, Koulibaly PM, Migneco O, Darcourt J., Pringuey DJ, Robert P.H. (2002) Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res. 114:103-111.
11. Berman K, Brodaty H, Withall A., Seeher K. (2012) Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry. 20:104-122.
12. Boone KB, Miller BL, Swartz R, Lu P., Lee A. (2003) Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc. 9:698-709.
13. Brodaty H, Burns K. (2012) Nonpharmacological management of apathy in dementia: a systematic review. Am J Geriatr Psychiatry. 20:549-564.
14. Brodaty H, Sachdev PS, Withall A, Altendorf A., Valenzuela MJ, Lorentz L. (2005) Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke: the Sydney Stroke Study. Psychol Med. 35:1707-1716.
15. Bruen PD, McGeown WJ, Shanks M.F., Venneri A (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain. 131:2455-2463.
16. Caputo M, Monastero R, Mariani E., Santucci A, Mangialasche F, Camarda R., Senin U, Mecocci P. (2008) Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand. 117:455e64.
17. Chow TW, Binns MA, Cummings J.L., Lam I., Black SE, Miller BL, Freedman M, Stuss D.T., van Reekum R (2009) Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol. 66:888-893.
18. Colling KB (1999) Passive behaviors in dementia. Clinical application of the needdriven dementia-compromised behavior model. J Gerontol Nurs. 25:27-32.
19. Corcoran C, Wong ML, O'Keane V (2004) Bupropion in the management of apathy. J Psychopharmacol. 18:133-135.
20. Cummings JL, Mega M, Gray K., Rosenberg-Thompson S, Carusi DA, Gornbein J. (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 44:2308-2314.
21. Cummings JL, Schneider L, Tariot P.N., Kershaw PR, Yuan W. (2004) Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. Am J Psychiatry. 161:532-538.
22. Cutting J (1995) Descriptive psychopathology. In Hirsch SR, Weinberger DR (Eds), Schizophrenia (pp 15-27). Oxford: Blackwell Science.
23. Devanand DP, Brockington CD, Moody B.J., Brown RP, Mayeux R, Endicott J, Sackeim H.A. (1992) Behavioral syndromes in Azheimer's disease. Int Psychogeriatr. 4(SUPPL. 2):161-184.
24. Diehl-Schmid J., Förstl H, Perneczky R., Pohl C, Kurz A. (2008) A 6-month, openlabel study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry. 23:754-759.
25. Dujardin K, Sockeel P, Delliaux M., Destée A, Defebvre L. (2009) Apathy may herald cognitive decline and dementia in Parkinson's disease. Movement Disorders 24:2391-2397.
26. Erkinjuntti T, Kurz A, Gauthier S., Bullock R, Lilienfeld S, Damaraju C.V. (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 359: 1283-1290.
27. Eslinger PJ, Grattan LM, Geder L.M. (1995) Impact of frontal lobe lesions on rehabilitation and recovery from acute brain injury. Neuro Rehabilitation. 5:161-182.
28. Eslinger PJ, Moore P, Antani S., Anderson C, Grossman M. (2012) Apathy in frontotemporal dementia: behavioral and neuroimaging correlates. Behav Neurol. 25:127-136.
29. Ferrero-Arias J., Goñi-Imízcoz M, González-Bernal J, Lara-Ortega F, da Silva González A, Díez-Lopez M (2011) The efficacy of nonpharmacological treatment for dementia-related apathy. Alzheimer Dis Assoc Disord. 25:213-219.
30. Finkel SI, Burns A. (2000) Introduction. Behavioral and psychological symptoms of dementia (BPSD): a clinical and research update. Int Psychogeriatr. 12(SUPPL. 1):9-12.
31. Freels S, Cohen D, Eisdorfer C., Paveza G, Gorelick P, Luchins D.J., Hirschman R., Ashford JW, Levy P, Semla T. (1992) Functional status and clinical findings in patients with Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 47: M177-M182.
32. Fuh JL, Wang SJ, Cummings J.L. (2005) Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 276:1337-1341.
33. Galynker I, Prikhojan A, Phillips E., Focseneanu M, Ieronimo C, Rosenthal R. (1997) Negative symptoms in stroke patients and length of hospital stay. J Nerv Ment Dis. 185:616-621.
34. Gauthier S, Juby A, Morelli L., Rehel B, Schecter R; EXTEND Investigators (2006) A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study. Curr Med Res Opin. 22:2251-2265.
35. Gilley DW, Wilson RS, Bienias J.L., Bennett DA, Evans D.A. (2004) Predictors of depressive symptoms in persons with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 59:P75-P83.
36. Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A., Paulsen JS, Jerkins S, Jacobson MW, Peavy G. (2003) Behavioral abnormalities contribute to functional decline in Huntington's disease. J Neurol Neurosurg Psychiatry. 74:120-122.
37. Hart DJ, Craig D, Compton S.A., Critchlow S., Kerrigan BM, McIlroy SP, Passmore A.P. (2003) A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry. 18:1037-1042.
38. Herrmann N, Rothenburg LS, Black S.E., Ryan M., Liu BA, Busto UE, Lanctôt KL (2008) Methylphenidate for the Treatment of Apathy in Alzheimer Disease. Prediction of Response Using Dextroamphetamine Challenge. J Clin Psychopharmacol. 28:296-301.
39. Holmes C, Wilkinson D, Dean C., Vethanayagam S, Olivieri S, Langley A., Pandita-Gunawardena ND, Hogg F, Clare C., Damms J. (2004) The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology. 63:214-219.
40. Holthoff VA, Beuthien-Baumann B, Kalbe E., Lüdecke S, Lenz O., Zündorf G, Spirling S., Schierz K, Winiecki P, Sorbi S., Herholz K. (2005) Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry. 57:412-421.
41. Kulisevsky J, Litvan I, Berthier M.L., Pascual-Sedano B, Paulsen JS, Cummings J.L. (2001) Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disorders. 16:1098-1104.
42. Landes AM, Sperry SD, Strauss M.E., Geldmacher D.S. (2001). Apathy in Alzheimer's disease. J Am Geriatr Soc. 49:1700-1707.
43. Lee HB, Lyketsos CG, Rao V. (2003) Pharmacological management of the psychiatric aspects of traumatic brain injury. Int Rev Psychiatry. 15:359-370.
44. Leroi I, Pantula H, McDonald K., Harbishettar V. (2012) Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia. Parkinson's Disease. 2012:308097.
45. Levy ML, Cummings JL, Fairbanks L.A., Masterman D., Miller BL, Craig AH, Paulsen JS, Litvan I. (1998) Apathy is not depression. J Neuropsychiatry Clin Neurosci. 10:314-319.
46. Levy R (2012) Apathy: a pathology of goal-directed behaviour: a new concept of the clinic and pathophysiology of apathy. Rev Neurol. 168:585-589.
47. Levy R, Dubois B. (2006) Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 16:916-928.
48. Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry. 147:22-30.
49. Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 3:243-254.
50. Marques FJ, Januário C (2012) J17Apathy prevalence and clinical correlations in Huntington's disease. J Neurol Neurosurg Psychiatry. 83:A41.
51. Marshall GA, Monserratt L, Harwood D., Mandelkern M, Cummings JL, Sultzer D.L. (2007) Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol. 64:1015-1020.
52. Massimo L, Powers C, Moore P., Vesely L, Avants B, Gee J., Libon DJ, Grossman M. (2009) Neuroanatomy of apathy and disinhibition in frontotemporal lobar de-generation. Dement Geriatr Cogn Disord. 27:96-104.
53. McKeith IG, Grace JB, Walker Z, Byrne E.J., Wilkinson D., Stevens T, Perry E.K. (2000) Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry. 15:387-392.
54. Mega MS, Cummings J.L. (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 6:358-370.
55. Mega MS, Cummings JL, Fiorello T, Gornbein J. (1996) The spectrum of behavioral changes in Alzheimer's disease. Neurology. 46:130-135.
56. Mendez MF, Lauterbach EC, Sampson SM; ANPA Committee on Research (2008) An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 20:130-149.
57. Moll J, Zahn R, Oliveira-Souza R, Krueger F., Grafman J.H. (2005) The neural basis of human moral cognition. Nat Rev Neurosci. 6:799-809.
58. Moretti R, Torre P, Antonello R.M., Cattaruzza T., Cazzato G, Bava A. (2004) Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging. 21:931-937.
59. Moretti R, Torre P, Antonello R.M., Cazzato G., Bava A. (2002) Depression and Alzheimer's disease: symptom or comorbidity? Am J Alzheimer's Dis Other Dement. 17:338-344.
60. Mortby ME, Maercker A, Forstmeier S. (2012) Apathy: a separate syndrome from depression in dementia? A critical review. Aging Clin Exp Res. 24: 305-316.
61. Naarding P, Janzing JG, Eling P, van der Werf S, Kremer B (2009) Apathy is not depression in Huntington's disease. J Neuropsychiatry Clin Neurosci. 21: 266-270.
62. Ott BR, Noto RB, Fogel B.S. (1996) Apathy and loss of insight in Alzheimer's disease: A SPECT imaging study. J Neuropsychiatry Clin Neurosci. 8:41-46.
63. Pantev M, Ritter R, Gortelmeyer R. (1993) Clinical and behavioural eveluation in long-term care patients with mild to modertae dementia under memantine treatment. Zeitschrt fur Gerontopsychologie Und-Psychiatrie. 6:S103-S117.
64. Paulsen JS, Ready RE, Hamilton J.M., Mega M., Cummings J. (2001) Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry. 71:310-314.
65. Piccininni M, Di Carlo A, Baldereschi M, Zaccara G., Inzitari D. (2005) Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord. 19:276-281.
66. Plenger PM, Dixon CE, Castillo R.M., Frankowski RF, Yablon SA, Levin HS (1996) Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil. 1996 77:536-540.
67. Potkin SG, Alva G, Gunay I., Koumaras B, Chen M, Mirski D. (2006) A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia. Drugs Aging. 23:241-249.
68. Reyes S, Viswanathan A, Godin O., Dufouil C, Benisty S, Hernandez K., Kurtz A, Jouvent E, O'Sullivan M, Czernecki V, Bousser M.G., Dichgans M., Chabriat H. (2009) Apathy: a major symptom in CADASIL. Neurology. 72:905-910.
69. Richard E, Schmand B, Eikelenboom P., Yang SC, Ligthart SA, Moll van Charante EP, van Gool WA (2012) Alzheimer's Disease Neuroimaging Initiative. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord 33:204-209.
70. Robert P, Onyike CU, Leentjens A.F., Dujardin K., Aalten P, Starkstein S, Verhey F.R., Yessavage J., Clement JP, Drapier D, Bayle F, Benoit M., Boyer P, Lorca PM, Thibaut F, Gauthier S., Grossberg G, Vellas B, Byrne J. (2009) Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. European Psychiaty. 2009; 24:98-104.
71. Robert PH, Clairet S, Benoit M., Koutaich J, Bertogliati C, Tible O., Caci H, Borg M, Brocker P., Bedoucha P. (2002) The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 17:1099-1105.
72. Rockwood K, Black S, Bedard M.A., Tran T., Lussier I; TOPS Study Investigators (2007) Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multicentre, primary care, open label study. Int J Geriatr Psychiatry. 22:312-319.
73. Sansone RA, Sansone L.A. (2010) SSRI-Induced Indifference. Psychiatry (Edgmont). 7:14-18.
74. Sato S, Asada T. (2011) Sertraline-induced apathy syndrome. J Neuropsychiatry Clin Neurosci. 23:E19.
75. Schmidt L, d'Arc BF, Lafargue G, Galanaud D., Czernecki V, Grabli D, Schüpbach M, Hartmann A., Lévy R, Dubois B., Pessiglione M. (2008) Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain. 131:1303-1310.
76. Snowden JS, Bathgate D, Varma A., Blackshaw A, Gibbons ZC, Neary D. (2001) Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 70:323-332.
77. Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F., van der Flier WM. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease (2010). J Neurol Neurosurg Psychiatry. 81:547-551
78. Starkstein SE (2000) Apathy and withdrawal. Int Psychogeriatr. 12(suppl 1): 135-138.
79. Starkstein SE, Ingram L, Garau M.L., Mizrahi R. (2005) On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005 76: 1070-1074.
80. Starkstein SE, Jorge R, Mizrahi R., Robinson R.G. (2006) A prospective longitudinal study of apathy in Alzheimer's disease J Neurol Neurosurg Psychiatry. 2006 77:8-11.
81. Starkstein SE, Merello M, Brockman S., Bruce D, Petracca G, Power B.D. (2009) Apathy predicts more severe parkinsonism in Alzheimer's disease. Am J Geriatr Psychiatry. 17:291-298.
82. Starkstein SE, Petracca G, Chemerinski E., Kremer J. (2001) Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 158:872-877.
83. Strauss ME, Sperry S.D. (2002) An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 15:176-183.
84. Tagariello P, Girardi P, Amore M. (2009) Depression and apathy in dementia: same syndrome or different constructs? A critical review. Arch Gerontol Geriatr. 49:246-249.
85. Tanaka M, Namiki C, Thuy D.H., Yoshida H., Kawasaki K, Hashikawa K, Fukuyama H., Kita T. (2004) Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease. J Neurol Sci. 225:135-141.
86. Tekin S, Mega MS, Masterman D.M., Chow T., Garakian J, Vinters HV, Cummings J.L. (2001) Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 49:355-361.
87. Turró-Garriga O, López-Pousa S, Vilalta-Franch J, Turón-Estrada A, Pericot-Nierga I, Lozano-Gallego M, Hernández-Ferràndiz M, Soler-Cors O, Planas-Pujol X, Monserrat-Vila S, Garre-Olmo J (2009) A longitudinal study of apathy in patients with Alzheimer's disease. Rev Neurol. 48:7-13.
88. van Duijn E., Reedeker N, Giltay E.J., Roos RA, van der Mast RC (2010) Correlates of apathy in Huntington's disease. J Neuropsychiatry Clin Neurosci. 22:287-294.
89. Van Reekum R., Stuss DT, Ostrander L. (2005) Apathy: why care? J Neuropsychiatry Clin Neurosci. 17:7-19.
90. Walker FO (2007) Huntington's disease. Lancet. 369:218-228.
91. Weiner MF, Martin-Cook K, Foster B.M., Saine K., Fontaine CS, Svetlik D.A. (2000) Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry. 61:487-492.
92. Winblad B, Poritis N. (1999) Memantine in severe dementia: results of the 9 M-Best Study (Benefit and efficacy in severely demented patients during treatmentwith memantine). Int J Geriatr Psychiatry. 14:135-146.
93. World Health Organisation (Ed) (1992) The ICD-10 classification of mental and behavioural disorders. Clinical description and diagnostic guidelines. Geneva.
94. Zafonte RD, Lexell J, Cullen N. (2001) Possible applications for dopaminergic agents following traumatic brain injury: part 2. J Head Trauma Rehabil. 16:112-116.
95. Zawacki TM, Grace J, Paul R., Moser DJ, Ott BR, Gordon N, Cohen R.A. (2002) Behavioral problems as predictors of functional abilities of vascular dementia patients. J Neuropsychiatry Clin Neuosci. 14:296-302.